Multimodality Imaging Can Help to Doubt, Diagnose and Follow-Up Cardiac Mass by Lee, Seung-Pyo et al.
555
Print ISSN 1738-5520 / On-line ISSN 1738-5555
Copyright © 2011 The Korean Society of Cardiology
CASE REPORT
http://dx.doi.org/10.4070/kcj.2011.41.9.555
Open Access
Multimodality Imaging Can Help to Doubt,  
Diagnose and Follow-Up Cardiac Mass
Seung-Pyo Lee, MD
1,2, Eue-Keun Choi, MD
1,2, Tae-Min Kim, MD
1, Eun-Ah Park, MD
3, 
Hyung-Kwan Kim, MD
1,2, Hyun-Jai Cho, MD
1,2, and Seil Oh, MD
1,2
1Departments of Internal Medicine, 
2Cardiovascular Center and 
3Radiology, Seoul National University Hospital, Seoul, Korea
ABSTRACT
Primary cardiac lymphoma is a very rare form of lymphoma primarily or mainly involving the heart, as in the two cases pre-
sented in this report. Various imaging modalities, including coronary computed tomography angiography, cardiac magnetic 
resonance imaging and positron emission tomography were useful for the characterization and diagnosis of cardiac mass. 
Pathologic confirmation was successful with endomyocardial biopsy under echocardiographic guidance, intra- and extracar-
diacally. In primary cardiac lymphoma, diagnosis using multiple modalities may be useful for mass characterization, and for 
response monitoring after chemotherapy. (Korean Circ J 2011;41:555-558)
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Introduction
Primary cardiac lymphoma is a form of non-Hodgkin’s 
lymphoma confined to or mainly located in the heart,
1) which 
is extremely rare in immunocompetent hosts. Here, we re-
port two cases of primary cardiac lymphoma, upon which 
coronary computed tomography angiography (CCTA), car-
diac magnetic resonance (CMR) imaging and positron emis-
sion tomography (PET) were useful to establish diagnosis. 
The mass was confirmed histologically by endomyocardial 
biopsy under the guidance transthoracic echocardiography 
(TTE) and intracardiac echocardiography (ICE).
Cases
Case 1
A 26-year-old, previous healthy man was referred to our 
emergency room for further treatment of complete atrioven-
tricular block (C-AVB) associated with a one-week history 
of exertional dyspnea, chest discomfort and dizziness. Twelve-
lead electrocardiogram (ECG) showed C-AVB without abnor-
mal findings on chest radiograph. Before implanting perma-
nent cardiac pacemaker, he underwent investigations for re-
versible causes of C-AVB. Coronary angiography showed in-
tact left and right coronary artery (Fig. 1A). However, CCTA 
revealed a large infiltrative hypo-attenuated mass involving 
the atrioventricular (AV) groove. The infiltrative mass circum-
ferentially encased the right coronary artery but did not com-
promise its lumen (Fig. 1B), which was strongly suggestive 
of cardiac lymphoma. The mass was demonstrated on TTE to 
be protruding into the right atrium (RA) and right ventricu-
lar cavity (Fig. 1C). A heterogeneously enhancing infiltrative 
mass involving the myo- and epicardium of both ventricular 
inferior wall along the AV groove was seen in CMR images 
(Fig. 2A). Transvenous endomyocardial biopsy (EMB) was 
performed under TTE guidance (Supplementary Figure On-
line A). Histology showed many mononuclear cells infiltrat-
ing the myocardium positive for CD3, CD4, negative for 
CD20 and highly positive for Ki-67, confirming the diagno-556   Multimodality Imaging & Primary Cardiac Lymphoma
sis of T lymphoblastic lymphoma (T-LBL). Whole-body PET 
showed hypermetabolic lesions at the cardiac base (Supple-
mentary Figure Online Ba). Chemotherapy comprised of 
cyclophosphamide, doxorubicin, vincristine, L-asparaginase 
(Stanford regimen) commenced after the diagnosis was con-
firmed, and appropriate staging procedures were conducted 
without delay, as the patient did not undergo sternotomy for 
pathologic diagnosis. During chemotherapy, the patient’s he-
art rate was maintained using isoproterenol continuous in-
fusion (1-2 μg/min). Follow-up CMR imaging, including st-
eady-state free procession, delayed enhanced MR (Fig. 2B) 
and whole-body PET imaging (Supplementary Figure Online 
Bb) confirmed near complete remission of C-AVB after one 
cycle of chemotherapy. The patient has been in complete re-
mission for 6 months. 
Case 2
A 54-year-old, previous healthy woman was referred to our 
emergency room with persistent nausea and chest discom-
fort. She had experienced 8 kg of weight loss in the past one 
year. Her initial systolic blood pressure (SBP) was 60 mmHg 
and cardiomegaly and pericardial effusion was respectively 
noted on chest radiograph and bedside echocardiography. 
Emergency pericardiocentesis was performed under the pre-
sumptive diagnosis of cardiac tamponade, and 700 mL of he-
mopericardium was drained immediately with recovery of 
SBP to normal soon after. A mass protruding from the poste-
rior surface of the RA into the atrial cavity was subsequently 
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Fig. 1. Angiographic and transthoracic echocardiographic findings of cardiac lymphoma at presentation in case 1. A: coronary angiography 
shows intact right coronary artery (arrows) and AV nodal artery (dotted arrows) without significant stenosis. B: coronary CT angiography 
shows preservation of the right coronary artery lumen in spite of the mass at the posterior surface and AV groove of the heart (arrowheads). 
The AV nodal artery was not compromised in both images. C: modified three chamber view by transthoracic echocardiography shows a 
mass protruding into the right atrium and right ventricle cavity (arrows), which was the target for endomyocardial biopsy. RCA: right coro-
nary artery, AVN a.: atrioventricular nodal artery, RA: right atrium, RV: right ventricle, LV: left ventricle.
Fig. 2. Cardiac magnetic resonance (CMR) findings of the cardiac lymphoma at presentation (A, upper row) and at follow-up after one cycle 
of chemotherapy (B, lower row) in case 1. A: iso to slightly high signal intensity mass (arrows) infiltrating the myocardium at the AV groove 
by steady state free precession (SSFP) image of cardiac MRI (Aa and Ab). Ten-minute delayed MR images with phase-sensitive inversion 
recovery technique after administration of gadopentetate dimeglumine demonstrated the infiltrative mass (arrows) clearly with heteroge-
neous enhancement (Ac). B: the mass (dotted arrows) size was markedly reduced after one cycle of chemotherapy in both SSFP (Ba and 
Bb) and delayed enhancement images with phase-sensitive inversion recovery (Bc). T1 (Ad and Bd) and T2 (Ae and Be) weight images 
also demonstrate significantly decreased intracardiac mass after chemotherapy.
A  
B  Seung-Pyo Lee, et al.   557
demonstrated on TTE (Fig. 3A), and confirmed by chest CT 
(Fig. 3B). CMR images demonstrated an infiltrative mass in-
volving the posterior surface of RA and interatrial septum 
(Fig. 3C). Transvenous EMB was performed under ICE guid-
ance (Supplementary Figure Online C). Histological analysis 
revealed many mononuclear cells infiltrating the myocardi-
um, positive for Igλ and highly positive for Ki-67, but nega-
tive for CD3 and CD20, suggestive of diffuse large B cell lym-
phoma, immunoblastic variant. Whole-body PET showed 
hypermetabolic lesions at the cardiac base (Supplementary Fi-
gure Online Da). Chemotherapy comprised of cyclophos-
phamide, doxorubicin, vincristine and rituximab commenc-
ed after the diagnosis was confirmed, and follow-up whole-
body PET images performed 7 weeks later showed reduction of 
the mass after two cycles (Supplementary Figure Online Db). 
Discussion
Primary cardiac lymphoma is an extremely type of lym-
phoma, the majority of which are of the B cell phenotype,
2) 
as seen in the second case. Although there have been case re-
ports and small case series of B cell lymphomas presenting 
as AV block,
3)4) the first case is one of the first to demonstrate 
that T cell lymphomas can also present as such. T-LBL dif-
fers from other types of B cell lineage lymphomas with its 
distinct clinical and biological features, such as high male 
predominance, and particularly, preponderance of mediasti-
nal involvement and lower chance of complete remission des-
pite adequate chemotherapy.
5) Therefore our first case is uni-
que in providing an infrequent presentation (C-AVB) of a rare 
disease entity (T-LBL) occurring at a very unusual site (heart) 
with favorable outcome, in contrast to two previous case re-
ports of T-LBL in the heart, the results of which were unfa-
vorable in the short-term (<1 month).
6)7) 
Among various diagnostic tools, TTE may be recommend-
ed as the initial modality because it readily assesses not only 
the hemodynamic status, but also the morphological abnor-
mality within the heart. TTE is also useful in guiding the EMB 
procedure,
8) which may be superior because it does not de-
lay chemotherapy initiation. Others have also suggested the 
use of ICE to guide biopsy,
9) which was the method that we 
adopted for the second case. Although transvenous biopsy 
imposes the risk of pulmonary embolism, the mass in our 
case did not look friable in all imaging modalities (TTE, CT 
and MRI) and also, firmly infiltrating the myocardium.
In contrast to the characteristic, operator-dependent per-
formance of ultrasonography, CMR may facilitate objective 
measurement of the mass and provides information on the 
characteristics of the mass, i.e., vascularity, homogeneity and 
necrosis. Similar to previous literature,
10) iso-intense but het-
erogeneous signal and diffusely infiltrating pattern of the 
mass without evidence of necrosis is a hallmark of cardiac 
lymphoma. The dramatic reduction of the lymphoma mass 
in our patient also shows that CMR may be helpful not only 
for diagnosis but for follow-up of cardiac lymphoma.
11) In ad-
dition, owing to the diffuse infiltrative pattern of the lympho-
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Fig. 3. Transthoracic echocardiography, chest CT and cardiac magnetic resonance findings of the cardiac lymphoma in case 2. A: subcos-
tal view showing a mass in the right atrium (arrows). B: chest CT image demonstrating a hemogeneously attenuated mass in the right atri-
um (arrows). C: mass infiltrating the posterior surface of the right atrium (arrows) and interatrial septum (dotted arrows) is demonstrated in 
steady state free precession (a, b and c), T1 (d) and T2 (e) images.558   Multimodality Imaging & Primary Cardiac Lymphoma
ma, it may be hard to demonstrate whether the lymphoma has 
genuinely regressed using other modalities (TTE or CT), 
which are generally poor for soft tissue characterization. Al-
though PET is considered a useful and even a standard mo-
dality for lymphoma follow-up recently, the poor spatial res-
olution of PET, complexity and the dynamicity of the heart 
structure and the high baseline metabolic rate of the heart 
renders PET a poor option for follow-up of cardiac lympho-
ma. In contrast, CMR with the help of late gadolinium en-
hancement as seen in the first case, may provide useful in-
formation to differentiate the mass and the myocardium. 
In conclusion, we report the usefulness of various imaging 
techniques in making a doubt, diagnosis and follow-up of 
rare primary cardiac lymphoma. As such, multimodality im-
aging may be helpful not only for proper diagnosis with less 
invasiveness but also for follow-up in such patients. 
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